These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Binding of adrenergic ligands ([3H]clonidine and [3H]WB-4101) to multiple sites in human brain. Weinreich P; Seeman P Biochem Pharmacol; 1981 Nov; 30(22):3115-20. PubMed ID: 6121557 [No Abstract] [Full Text] [Related]
6. Alpha-adrenergic receptors in liver membranes: delineation with subtype selective radioligands. Hoffman BB; Dukes DF; Lefkowitz RJ Life Sci; 1981 Jan; 28(3):265-72. PubMed ID: 6261059 [No Abstract] [Full Text] [Related]
7. Subtype specificity of alpha-adrenergic receptors in rat heart. Williams RS; Dukes DF; Lefkowitz RJ J Cardiovasc Pharmacol; 1981; 3(3):522-31. PubMed ID: 6168833 [TBL] [Abstract][Full Text] [Related]
8. Changes in alpha-adrenergic receptors in rat brain in vitro by preincubation with alpha-adrenergic ligands. Hata F; Uchida S; Takeyasu K; Ishida H; Yoshida H Jpn J Pharmacol; 1980 Aug; 30(4):570-4. PubMed ID: 6110794 [No Abstract] [Full Text] [Related]
9. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine. Motulsky HJ; Insel PA Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of alpha 2-adrenergic receptors in human myometrium by [3H]rauwolscine binding. Bottari SP; Vokaer A; Kaivez E; Lescrainier JP; Vauquelin G Am J Obstet Gynecol; 1983 Jul; 146(6):639-43. PubMed ID: 6135347 [TBL] [Abstract][Full Text] [Related]
12. An assay for alpha-adrenergic receptor subtypes using [3H]dihydroergocryptine. Hoffman BB; Lefkowitz RJ Biochem Pharmacol; 1980 Feb; 29(3):452-4. PubMed ID: 6244840 [No Abstract] [Full Text] [Related]
13. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Morrow AL; Creese I Mol Pharmacol; 1986 Apr; 29(4):321-30. PubMed ID: 3010073 [TBL] [Abstract][Full Text] [Related]
14. Determination of subtype selectivity of alpha-adrenergic antagonists: comparison of selective and nonselective radioligands. Lavin TN; Hoffman BB; Lefkowitz RJ Mol Pharmacol; 1981 Jul; 20(1):28-34. PubMed ID: 6117003 [No Abstract] [Full Text] [Related]
15. In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors. Massingham R; Dubocovich ML; Shepperson NB; Langer SZ J Pharmacol Exp Ther; 1981 May; 217(2):467-74. PubMed ID: 6112260 [No Abstract] [Full Text] [Related]
16. The alpha 2-adrenergic receptor of human fat cells: comparative study of alpha 2-adrenergic radioligand binding and biological response. Berlan M; Lafontan M J Physiol (Paris); 1982; 78(3):279-87. PubMed ID: 6300379 [No Abstract] [Full Text] [Related]
18. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors. Guicheney P; Meyer P Br J Pharmacol; 1981 May; 73(1):33-9. PubMed ID: 6269682 [TBL] [Abstract][Full Text] [Related]
19. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652 [TBL] [Abstract][Full Text] [Related]
20. Characterization of alpha-adrenergic receptor subtypes in rat brain: estimation of ability of adrenergic ligands to displace 3H-dihydroergocyrptine from the receptor subtypes. Haga T; Haga K Life Sci; 1980 Jan; 26(3):211-8. PubMed ID: 6244473 [No Abstract] [Full Text] [Related] [Next] [New Search]